GlassScriptPhysician profile
Dorothea T Watson
NPI 1184744328
$371.55
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $22.92 · 2022: $137 · 2023: $90.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $61.26 | 2019-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $51.65 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.23 | 2019-2023 | Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $43.77 | 2022 | |
| Sunovion Pharmaceuticals INC. | $40.88 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.74 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $22.55 | 2022 | |
| Mylan Specialty L.P. | $20.57 | 2023 | Yupelri |
| Genentech USA, INC. | $17.58 | 2019 | |
| Shire North American Group INC | $14.34 | 2019 | |
| Genzyme Corporation | $13.17 | 2022 | |
| Jazz Pharmaceuticals INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorothea Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.